CAS: 4965-36-0; 7-Bromoquinoline

该化合物是一种卤化的quinoline衍生物,广泛用作有机合成和制药研究的多用途中间体,其7种位置的溴替代物可增强反应性,促进相互交织的反应,如Suzuki-Miyaura或Buchwald-Hartwig,使其对建设复杂的热循环框架很有价值.该化合物具有高度纯度和稳定性,确保催化和药用化学应用的一贯性能.其结构特征还有利于改造生物活性分子,包括潜在的药物候选分子.在受控制的条件下使用,7-Bromoquinoline是合成先进材料和专门精密化学品的关键建筑块.

结构式图片

相似化合物

700871-88-1 4964-71-0 3964-04-3

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号333383-82-7 N-(3-bromopheny... | CAS号333383-83-8 N-(3-bromopheny... | CAS号591-19-5 3-溴苯胺 | CAS号7510-48-7 N-(3-溴苯基)-4-甲基苯磺酰胺 | CAS号83922-51-4 N-(3-溴苯基)甲烷磺酰胺 | CAS号56-81-5 甘油 | CAS号4964-76-5 7-甲氧基喹啉 | CAS号851985-81-4 7-(4,4,5,5-四甲基-... | CAS号85656-65-1 7-溴喹啉-8-胺 | CAS号89770-32-1 DIMETHYL-QUINOL... | CAS号443692-93-1 喹啉-7-磺酰氯

合成工艺路线路线简述

  • 合成目标产物 7-Bromoquinoline 主要起始原料 3-Bromoaniline
  • (文献来源)合成步骤主要原料 3-Bromoaniline
N-(3-Bromophenyl)-4-Methyl-Benzenesulfonamide置于三氟甲磺酸,三乙胺体系中,用 甲醇,二氯甲烷 作为反应溶剂,化学反应 0.17H,反应生成 7-溴喹啉
参考文献:Tokuyama,Hidetoshi; Sato,Masashi; Ueda,Toshihiro,Heterocycles,2001,Vol. 54,# 1,P. 105-108
标题:Tokuyama,Hidetoshi; Sato,Masashi; Ueda,Toshihiro,Heterocycles,2001,Vol. 54,# 1,P. 105-108

海关参考信息

专利信息


专利号:US-11299484-B2
优先权日:2018-10-10
标 题 :Inhibiting fatty acid synthase (FASN)
发明人:MARTIN MATTHEW W; ZABLOCKI MARY-MARGARET; MENTE SCOT; DINSMORE CHRISTOPHER; WANG ZHONGGUO; ZHENG XIAOZHANG
权利人:FORMA THERAPEUTICS INC
摘要:The present disclosure is directed to inhibitors of FASN. The compounds can be useful in the treatment of disease or disorders associated with the inhibition of FASN. For instance, the disclosure is concerned with compounds and compositions for inhibition of FASN, methods of treating, preventing, or ameliorating diseases or disorders associated with the inhibition of FASN, and methods of synthesis of these compounds.

专利号:CN-118146153-A
优先权日:2024-02-28
标 题 :Synthesis of bicyclo[1.1.1]pentane-1-acid and amine derivatives

专利号:WO-9531458-A1
优先权日:1992-10-13
标 题:3-hydroxyquinuclidin-3-ylphenylquinolines as squalene synthase inhibitors
发明人:NEUENSCHWANDER KENT W; GRONEBERG ROBERT D; MORRIS ROBERT L; SCOTESE ANTHONY C; MAGUIRE MARTIN P
权利人:RHONE POULENC RORER PHARMA; NEUENSCHWANDER KENT W; GRONEBERG ROBERT D; MORRIS ROBERT L; SCOTESE ANTHONY C; MAGUIRE MARTIN P
摘要:This invention relates to a class of novel compounds useful in the treatment of diseases associated with undesirable cholesterol levels in the body, and particularly diseases of the cardiovascular system, such as atherosclerosis. The compounds of this invention are novel quinolinyl phenyl 3-hydroxyquinuclidines which may be linked directly or through a chain linking the quinolinyl to the phenyl and/or the phenyl to the quinuclidine. Compounds of this invention exhibit squalene synthase inhibition properties and reduce levels of serum cholesterol without significantly reducing mevalonic metabolite synthesis and thus provide a therapeutic agent having fewer side effects than agents which act by inhibiting the HMG-CoA reductase enzyme. Compounds of the present invention may also be useful in treating fungal infections. This invention further relates to pharmacological compositions and method of treatment for lowering serum cholesterol levels using the compounds of this invention.

专利号:US-7897774-B2
优先权日:2005-03-03
标题:Cyclic compound having quinolylalkylthio group
发明人:KAWASHIMA KENJI; HONDA TAKAHIRO; TAJIMA HISASHI; OKAMOTO KAZUYOSHI; YAMAMOTO MINORU
权利人:SANTEN PHARMACEUTICAL CO LTD
摘要:The present invention relates to a synthesis study of novel cyclic compounds having a quinolylalkylthio group represented by the formula (1), and pharmacological actions of the compounds. n nIn the formula, the ring X represents:n n nwhich may have halogen and/or alkyl; R 1 and R 2 independently represent hydrogen, alkyl, cycloalkyl, aryl or a (non) aromatic heterocycle; R 3 represents qinolyl; A represents sulfur, sulfinyl or sulfonyl; and B represents alkylene.

专利号:CN-106588926-A
优先权日:2016-12-28
标 题 :A kind of 2,7-diaza[3,2,1]bicyclooctane and its derivatives and their synthesis method and application

专利号:CN-106588926-B
优先权日:2016-12-28
标题:A kind of 2,7-diaza[3,2,1]bicyclooctane and its derivatives and their synthesis method and application
泰兴市可得利化工制造有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.kedelichem.com
企业联系电话:18961021086👤
📞泰兴市可得利化工制造有限公司 ⚠️参考联系方式
联系人:刘明荣
电话:18961021086
手机:18961021086
传真:0523-84850485
邮箱:sales@kelidechem.com
通信地址: 江苏省泰州泰兴市珊瑚镇八户村
邮编:
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省泰州泰兴市珊瑚镇八户村
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
宁波市海曙铭浩医药化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.mhpharm.com.cn
企业联系电话:0574-88285925👤
📞宁波市海曙铭浩医药化工有限公司 ⚠️参考联系方式
联系人:盛先生 蔡小姐
电话:0574-88285925
手机:18657682767;13396618955
传真:0574-88425889
邮箱:sales@mhpharm.com.cn
通信地址: 宁波市海曙区横街镇金泉路3号
邮编: 317000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:宁波市海曙区横街镇金泉路3号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Liao, L.; Zhang, Y.; Yu, J.-S., Science of Synthesis: Knowledge Updates, (2024) 1, 240.
摘要:Migliorini, F.; Puglioli, S.; Neri, D.; Cazzamalli, S.; Favalli, N., Science of Synthesis: DNA-Encoded Libraries, (2024) nan, 126.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知